Beam Therapeutics Inc (NAS:BEAM)
$ 23.765 -0.595 (-2.44%) Market Cap: 1.96 Bil Enterprise Value: 1.16 Bil PE Ratio: 0 PB Ratio: 2.29 GF Score: 54/100

Beam Therapeutics Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript

Dec 01, 2022 / 01:50PM GMT
Release Date Price: $45.83 (-0.78%)
Liisa Bayko
Evercore ISI - Analyst

Hi, good morning. My name is Liisa Bayko. Welcome to HealthCONx 2022. I'm very pleased today to be talking to Beam, which is one of the leaders in the gene editing space. And I would say the company has the coolest lab. We had a pleasure of visiting Beam in Boston as part of our bus tour last spring, and just love your labs. They're just so cool.

John Evans
Beam Therapeutics Inc. - CEO & Board Member

Thank you.

Questions & Answers

Liisa Bayko
Evercore ISI - Analyst

Anyone gets a chance to go there, I highly recommend. But I want to turn it over to you guys and maybe just to set the tone of the conversation. Maybe you can start with a quick overview of Beam.

John Evans
Beam Therapeutics Inc. - CEO & Board Member

Sure. So it's great to be here. Thank you. And yes, our labs are very cool. And everyone's welcome anytime. We're right in Cambridge. So Beam is a next-generation gene editing company. So we're using a new

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot